Event-Driven Stocks

Assertio Holdings, Inc.

ASRTNasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 1 good● 4 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$118.7M$125.0M$152.1M$156.2M$111.0M$106.3M
Operating income−$21.5M−$24.5M−$243.5M$39.4M$9.4M−$82.2M
Net income−$30.4M−$21.6M−$331.9M$109.6M−$1.3M−$28.1M
Total assets$267.0M$284.7M$286.4M$413.9M$326.5M$303.3M
Total liabilities$173.0M$163.7M$148.4M$188.2M$224.1M$247.8M
Equity$94.0M$121.1M$138.0M$225.7M$102.4M$55.5M
EPS (diluted)$-4.74$-3.40$-4.67$2.03$-0.03$-1.07
Shares out.95.8M95.0M55.6M45.3M173.4M28.4M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−18.1%
Net margin
−25.6%
Return on equity
−32.3%
Return on assets
−11.4%
Return on capital (ROCE)
−15.4%
Liabilities / assets
64.8%
Debt / equity
1.84×
Book value / share
$0.98
Revenue growth (YoY)
−5.0%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-6.37distress
Accruals / assets
−0.8%clean
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
30
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 67Financial strength 50

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 4 warning● 1 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026249,2991.0-13.8%
Apr 30, 2026289,2821.3+0.7%
Apr 15, 2026287,2411.1-4.8%
Mar 31, 2026301,8371.4+24.8%
Mar 13, 2026241,9328.1-5.2%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)